BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 3978626)

  • 21. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by hamster embryo cells.
    Baird WM; Salmon CP; Diamond L
    Cancer Res; 1984 Apr; 44(4):1445-52. PubMed ID: 6322978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
    Ioannou YM; Wilson AG; Anderson MW
    Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant activation of benzo(a)pyrene in cultured rat mammary cells in vitro and following direct application to rat mammary glands in vivo.
    Phillips DH; Hewer A; Grover PL
    Cancer Res; 1985 Sep; 45(9):4167-74. PubMed ID: 3928151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
    Rojas M; Alexandrov K
    Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of covalent DNA adducts in mouse epidermal subpopulations after topical application of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene.
    Baer-Dubowska W; Morris RJ; Gill RD; DiGiovanni J
    Cancer Res; 1990 May; 50(10):3048-54. PubMed ID: 2110503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis.
    Smolarek TA; Baird WM; Fisher EP; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3701-6. PubMed ID: 3109730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic activation of benzo(a)pyrene in SENCAR and BALB/c mouse embryo cell cultures.
    Baird WM; Sebti SM; Reinsvold LA
    Environ Health Perspect; 1986 Sep; 68():45-52. PubMed ID: 3780631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
    Anderson MW; Boroujerdi M; Wilson AG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.
    Ploch SA; King LC; Kohan MJ; Di Giulio RT
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):90-8. PubMed ID: 9512731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
    Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
    Adriaenssens PI; White CM; Anderson MW
    Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide.
    Zhan DJ; Heflich RH; Fu PP
    Environ Mol Mutagen; 1996; 27(1):19-29. PubMed ID: 8625944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits.
    Horton JK; Rosenior JC; Bend JR; Anderson MW
    Cancer Res; 1985 Aug; 45(8):3477-81. PubMed ID: 3926299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative metabolism of benzo(a)pyrene and covalent binding to hepatic DNA in English sole, starry flounder, and rat.
    Varanasi U; Nishimoto M; Reichert WL; Le Eberhart BT
    Cancer Res; 1986 Aug; 46(8):3817-24. PubMed ID: 3731058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
    Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of and DNA adduct formation by benzo[alpha]pyrene in human skin epithelial cells in vitro pretreated with cytochrome P450 modulators.
    Lehman TA; Kurian P; Milo GE
    Cancer Biochem Biophys; 1989 Oct; 10(4):345-52. PubMed ID: 2515917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathione depletion suppresses conjugation of benzo[a]pyrene metabolites and (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene metabolites with glutathione but does not affect their binding to DNA in C3H/10T1/2 mouse fibroblasts.
    Hesse S; Krupski-Brennstuhl G; Cumpelik O; Mezger M; Wiebel FJ
    Carcinogenesis; 1987 Aug; 8(8):1051-8. PubMed ID: 3608089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
    Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
    IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.